ClearBridge Investments’s Albany Molecular Research Inc AMRI Stock Holding History

ClearBridge Investments’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-15,310	Closed	-$332K	–	1236
2017 Q2	$332K	Buy	+15,310	New	+$278K	﹤0.01%	714

Other funds holding AMRI

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

ClearBridge Investments's AMRI Position: Q3 2017 in Review

ClearBridge Investments sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 15,310 shares — an estimated $332K sold.

ClearBridge Investments first reported a position in AMRI in Q2 2017 and held it in 1 quarter. The position peaked at $332K in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

ClearBridge Investments reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
ClearBridge Investments sold 15,310 Albany Molecular Research Inc shares in Q3 2017, an estimated $332K.
ClearBridge Investments first reported a position in Albany Molecular Research Inc in Q2 2017 and held it in 1 quarter.
ClearBridge Investments's Albany Molecular Research Inc position peaked at $332K in Q2 2017.
2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on ClearBridge Investments's 13F filing for Q3 2017, filed 14 Nov 2017.